HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multi-phase postmortem CT angiography (MPMCTA): a new axillary approach suitable in fatal thromboembolism.

Abstract
Postmor tem computed tomography is widely used in the forensic pathology setting as supplementing medico-legal investigations and being capable of providing significant data that affect final conclusions and adding new quality to recording postmortem observations. The integration with angiographic methods [postmortem computed tomography angiography and multiphase postmortem CT angiography (MPMCTA)] allows the examination of the cardiovascular system and it is increasingly being utilised in the field of forensic pathology. However, using the standardised procedure that establishes the femoral vessels on one side of the corpse as an access point to the vascular system, visualisation of the vascular tree below the cannula insertion site is excluded. Consequently, visualisation of the vascular anatomy and morphology of the lower limbs is impossible and lesions such as thrombosis of the superficial and deep venous system may remain elusive. Bearing in mind the high incidence of pulmonary thromboembolism in forensic case studies and the difficulties in postmortem diagnosis, we propose a new axillary approach for MPMCTA that allows the full detection of the vascular system of the lower limbs.
AuthorsCristoforo Pomara, Stefania Bello, GianPaolo Grilli, Giuseppe Guglielmi, Emanuela Turillazzi
JournalLa Radiologia medica (Radiol Med) Vol. 120 Issue 7 Pg. 670-3 (Jul 2015) ISSN: 1826-6983 [Electronic] Italy
PMID25348139 (Publication Type: Journal Article)
Topics
  • Angiography (methods)
  • Autopsy (methods)
  • Axilla
  • Humans
  • Thromboembolism (diagnostic imaging)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: